Have a personal or library account? Click to login
Thrombotic Markers in Plasma as Predictors of Response in Rheumatoid Arthritis Patients Treated with Baricitinib – Pilot Observation Cover

Thrombotic Markers in Plasma as Predictors of Response in Rheumatoid Arthritis Patients Treated with Baricitinib – Pilot Observation

Open Access
|Apr 2025

Authors

Anna Felis-Giemza

annafelis@wp.pl

Biologic Therapy Center and Central Clinical Laboratory, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Kornelia Chmurzynska

Department of Connective Tissue Diseases, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Jakub Wronski

Department of Rheumatology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Paulina Klimek

Central Clinical Laboratory, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Anna Kornatka

Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Wlodzimierz Maslinski

Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Marzena Ciechomska

Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

Magdalena Massalska

Department of Pathophysiology and Immunology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland
Language: English
Submitted on: Sep 12, 2024
Accepted on: Jan 28, 2025
Published on: Apr 9, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Anna Felis-Giemza, Kornelia Chmurzynska, Jakub Wronski, Paulina Klimek, Anna Kornatka, Wlodzimierz Maslinski, Marzena Ciechomska, Magdalena Massalska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.